Beigene Ltd ADR (NQ: BGNE )
143.71
+4.72
(+3.40%)
Streaming Delayed Price
Updated: 3:29 PM EDT, Apr 24, 2024
Add to My Watchlist
Headline News about Beigene Ltd ADR
Evaluating BeiGene: Insights From 6 Financial Analysts
Today 14:01 EDT
Via Benzinga
4 Analysts Assess BeiGene: What You Need To Know
March 27, 2024
Via Benzinga
Via Talk Markets
Citigroup Maintains Buy Rating for BeiGene: Here's What You Need To Know
September 21, 2023
Via Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Via Benzinga
Exposures
Product Safety
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
October 30, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Week In Review: China's Biopharmas Announce $2.5 Billion In Deals
October 21, 2023
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via Benzinga
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.